Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine.

Hypercholesterolemia reduces vascular nitric oxide (NO) activity. This dysfunction may promote endothelial monocyte interaction, as NO is a potent inhibitor of cell adhesion. We have previously shown that in hypercholesterolemic (HC) rabbits, chronic oral supplementation of L-arginine (Arg) restores NO activity and inhibits monocyte-endothelial cell interaction, in association with a reduction in atherogenesis. We hypothesized that enhancement of endothelial NO activity in HC humans would reduce monocyte adhesiveness. We used a functional binding assay to assess the adhesiveness of human mononuclear cells (MNCs) ex vivo to determine the effects of hypercholesterolemia and L-arginine administration. MNCs from HC subjects adhered in greater numbers (50% more cells per high-power field; P < .0001) than cells derived from normocholesterolemic (NC) subjects. To determine whether enhancement of endogenous NO activity could inhibit mononuclear cell adhesiveness, in a double-blinded placebo-controlled study, oral arginine HCl (8.4 g/d) was administered to HC subjects. Over a course of 2 weeks, this treatment abolished the increased adhesiveness of HC MNCs (160 +/- 11% versus 104 +/- 5%; before and after 2 weeks of Arg treatment; results expressed as a percentage of the binding values obtained using cells derived from paired NC individuals). By contrast, MNC adhesion remained significantly elevated in placebo-treated HC subjects. To examine whether endothelium-derived NO could act as a paracrine modulator of monocyte behavior, monocytes were exposed to NO donors or cocultered in the presence of endothelial cells exposed to antagonists of NO synthase in the presence or absence of L-arginine. NO donors inhibited monocyte adhesiveness. Furthermore, the adhesiveness of monocytes cocultured with endothelial cells was increased by antagonists of NO synthase; this effect was reversed by L-arginine. This study shows that the adhesiveness of human MNCs is increased by hypercholesterolemia. The increase in adhesiveness was reversed in vivo by administration of the NO precursor L-arginine. NO donors or endothelium-derived NO inhibits the adhesiveness of monocytes in vitro, supporting the hypothesis that the effects of L-arginine are mediated by NO.

[1]  S. Bode-Böger,et al.  Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. , 1997, Circulation.

[2]  P. Vallance,et al.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase , 1996, British journal of pharmacology.

[3]  S. Bode-Böger,et al.  Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. , 1996, Biochemical and biophysical research communications.

[4]  J P Cooke,et al.  Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. , 1995, Circulation.

[5]  D. Celermajer,et al.  Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. , 1995, Journal of the American College of Cardiology.

[6]  R. Brandes,et al.  Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. , 1995, Atherosclerosis.

[7]  P. Tsao,et al.  L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  P. Kubes,et al.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. , 1994, Circulation research.

[9]  R. Cohen,et al.  Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  P. Tsao,et al.  Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. , 1994, Circulation.

[11]  S. Lundin,et al.  Nitric Oxide Synthesis and Metabolism in Man , 1994, Annals of the New York Academy of Sciences.

[12]  U. Walter,et al.  Endothelium-dependent phosphorylation of vasodilator-stimulated protein in platelets during coronary passage. , 1994, The American journal of physiology.

[13]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[14]  J. Stamler,et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.

[15]  J. Cooke,et al.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.

[16]  P. Tsao,et al.  Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. , 1992, The Journal of clinical investigation.

[17]  G. Zimmerman,et al.  Novel leukocyte agonists are released by endothelial cells exposed to peroxide. , 1992, The Journal of biological chemistry.

[18]  K. Messmer,et al.  Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  H. Drexler,et al.  Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.

[20]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Palmer,et al.  Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  J. Cooke,et al.  Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta , 1991, Circulation.

[23]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[24]  D. Harrison,et al.  Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.

[25]  L. Orci,et al.  Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene , 1990, Cell.

[26]  F. Parhami,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[28]  R. Busse,et al.  EDRF Increases Cyclic GMP in Platelets During Passage Through the Coronary Vascular Bed , 1989, Circulation research.

[29]  J. Stamler,et al.  N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. , 1989, Circulation research.

[30]  K. Zitnay,et al.  Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.

[31]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[32]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[33]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[34]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[35]  W. Edwards.  Blood Vessels , 1959 .

[36]  D. Tsikas,et al.  L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. , 1996, Circulation.

[37]  P. Tsao,et al.  Regression or progression. Dependency on vascular nitric oxide. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Yuan‐jian Li,et al.  Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. , 1994, Life sciences.

[39]  W. J. Visek,et al.  Arginine needs, physiological state and usual diets. A reevaluation. , 1986, The Journal of nutrition.